STERIS PLC IRELAND overview

DERBY, U.K. - February 19, 2019 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Raymond James Institutional Investor Conference on Monday, March 4, 2019. Michael J. Tokich, STERIS's Senior Vice President and Chief Financial Officer will present at 8:40 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to...

Third quarter revenue grows 5% as reported and 7% on a constant currency organic basis As reported earnings per diluted share of $0.56 reflect restructuring charge of approximately $35 million Adjusted earnings per diluted share increase 13% to $1.26 DERBY, U.K. - (February 11, 2019) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 third quarter ended December 31, 2018. Revenue as reported for the quarter increased 5% to $696.2 million...

DERBY, U.K. - January 29, 2019- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 third quarter financial results at 10:00 a.m. Eastern Time on Tuesday, February 12, 2019. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. For those unable to...

DERBY, U.K. - December 18, 2018 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the J.P. Morgan Healthcare Conference on Monday, January 7, 2019. Walt Rosebrough, STERIS's President and CEO, will present at 3:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our Customers create a healthier and safer...

Approximately $45 million restructuring charge to be recorded in fiscal 2019, of which approximately $35 million is non-cash Annual profit improvement of approximately $12 million anticipated by fiscal 2021 DERBY, UK (December 4, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced a targeted restructuring plan, which includes the closure of two manufacturing facilities, one in Brazil and one in England, as well as other actions including product rationalization. Less than...

Second quarter revenue grows 7% as reported and 9% on a constant currency organic basis As reported EPS grows 21% and adjusted EPS grows 17% Company increases outlook for full year fiscal 2019 Company plans redomicile to Ireland DERBY, U.K. - (November 6, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 second quarter ended September 30, 2018. Revenue as reported for the quarter increased 7% to $679.0 million compared with $634.2...

DERBY, U.K. - October 23, 2018 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Stephens NY Investment Conference on Wednesday, November 7, 2018. Michael J. Tokich, STERIS's Senior Vice President and Chief Financial Officer, will present at 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our...